Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants
Clinical trial NCT03188692 · COMPLETED
Trial details
- NCT number
- NCT03188692
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-23
- Primary completion
- 2017-11-02
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.